-
Virtual Connection in a Time of Social DistanceResponding to the coronavirus, patient advocates and nonprofits expand existing outreach initiatives and launch new ones.
by Marci A. Landsmann
-
Cancer Treatment During a PandemicPeople being treated for cancer may be at elevated risk of developing severe cases of COVID-19. The coronavirus is also affecting how cancer care is delivered.
by William G. Nelson, MD, PhD
-
Testing Cancer Patients for the CoronavirusCancer centers are taking advantage of their in-house molecular laboratories to selectively test certain cancer patients for the coronavirus.
by Anna Azvolinsky
-
A Unified StrategyA couple who lost their daughter to brain cancer builds a charity that connects parents, hospitals and researchers with data.
by Marci A. Landsmann
-
The Coronavirus Impacts Cancer Clinical TrialsThe National Cancer Institute and the Food and Drug Administration have provided guidance for managing clinical trials amid the spread of the novel coronavirus. Cancer centers are making changes to care for some patients enrolled in trials.
by Anna Azvolinsky
-
The Coronavirus and Cancer CareCancer patients in the U.S. are feeling impacts from the new coronavirus.
by Kate Yandell
-
Medicare Coverage for Next-Generation Sequencing TestsMultigene panels that rely on next-generation sequencing are increasingly used to test for hereditary cancer risk-related mutations. The federal government aims to expand Medicare coverage for these tests.
by Ashley P. Taylor
-
For Prostate Biopsy, It’s Best to Combine Old and New MethodsUsing an older method of prostate biopsy together with MRI-targeted biopsy more accurately diagnoses prostate cancer than either method alone, a study finds.
by Kate Yandell
-
On Cancer and IdentityThe first time Liza Bernstein was diagnosed with cancer, she wouldn't allow it to be part of her identity. After her third cancer diagnosis, she became an advocate for other patients.
by Liza Bernstein
-
Despite Generic Imatinib, Cost of Treating CML Remains HighThe arrival of generic versions of the targeted therapy imatinib only modestly reduced the cost of treating chronic myelogenous leukemia patients, a study finds.
by Anna Azvolinsky
ASCO and the Society for Integrative Oncology issue recommendations for integrative medicine approaches that have been supported with research.
by Teresa Bergen
A Look at Disparities Across Cancer CareA new AACR report tracks progress in addressing cancer health disparities and identifies work that still needs to be done.
by Eric Fitzsimmons
Credit Agencies to Remove Some Medical Debt From ReportsChanges to what medical debt is included in credit reports could give patients more time to resolve outstanding bills.
by Karon Warren
The Mental Toll of a Cancer DiagnosisNew studies shine a light on the effects of a cancer diagnosis on mental health and suicide risk.
by Pamela Rafalow Grossman
-
Using Lymphocytes to Attack TumorsSooner rather than later may be the best strategy for using an experimental treatment for advanced melanoma.
-
Closing Disparities Through Genetic TestingOlufunmilayo Olopade seeks widespread use of testing to encourage prevention and early detection of deadly cancers.
Learning Medicare’s ABCDs
